Pharmacokinetics and pharmacodynamics of a single bolus of propofol 2% in healthy volunteers

Journal of Clinical Pharmacology

Volumn 43, Issue 4, 2003, Pages 397-405

  Abad Santos, Francisco ^a   Gálvez Múgica, Ma Angeles ^a   Santos, Ma Angeles ^a   Novalbos, Jesús ^a   Gallego Sandín, Sonia ^a   Méndez, Paloma ^b   Casimiro, Cesar ^b   Gilsanz, Fernando ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b ABBOTT LABORATORIES   (Spain)

Author keywords

Anesthetics; Bioequivalence; Healthy volunteers; Intravenous; Pharmacodynamics; Pharmacokinetics; Propofol

Indexed keywords

AMOXICILLIN; ATROPINE; PROPOFOL;

ADULT; APNEA; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; BOLUS INJECTION; BRADYCARDIA; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONSCIOUSNESS; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG HALF LIFE; DRUG SAFETY; FLU LIKE SYNDROME; FLUORESCENCE; HEADACHE; HEMODYNAMIC MONITORING; HUMAN; HUMAN EXPERIMENT; HYPERBILIRUBINEMIA; HYPNOSIS; INFLAMMATION; INJECTION SITE; MALE; NORMAL HUMAN; PAIN; PHARMACODYNAMICS; RANDOMIZED CONTROLLED TRIAL; REVERSED PHASE LIQUID CHROMATOGRAPHY;

ADULT; ANESTHETICS, INTRAVENOUS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CROSS-OVER STUDIES; HUMANS; MALE; PROPOFOL; THERAPEUTIC EQUIVALENCY; TIME FACTORS;

EID: 0037379572     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270003251391     Document Type: Article

References (17)

1. Bryson HM, Fulton BR, Faulds D: Propofol: an update of its use in anaesthesia and conscious sedation. Drugs 1995;50:513-559.
2. Fulton B, Sorkin EM: Propofol: an overview of its pharmacology and a review of its clinical efficacy in intensive care sedation. Drugs 1995;50:636-657.
3. Langley MS, Heel RC: Propofol: a review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthesia. Drugs 1988;35:334-372.
4. Kanto J, Gepts E: Pharmacokinetic implications for the clinical use of propofol. Clin Pharmacokinet 1989;17:308-326.
5. Cummings GC, Dixon J, Kay NH, Windsor JP, Major E, Morgan M, et al: Dose requirements of ICI 35,868 (propofol, 'Diprivan') in a new formulation for induction of anaesthesia. Anaesthesia 1984;39:1168-1171.
6. Dutta S, Ebling WF: Formulation-dependent pharmacokinetics and pharmacodynamics of propofol in rats. J Pharm Pharmacol 1998; 50:37-42.
7. European Agency for the Evaluation of Medicinal Products (EMEA), Committee for Proprietary Medicinal Products (CPMP): Note for Guidance on the Investigation of Bioavailability and Bioequivalence. London: EMEA, 2001.
8. Food and Drug Administration (FDA), U.S. Department of Health and Human Services, Center for Drug Evaluation and Research (CDER): Guidance for Industry: BA and BE Studies for Orally Administered Drug Products: General Considerations. Rockville, MD: FDA, 2000.
9. Doenicke AW, Roizen MF, Rau J, O'Connor M, Kugler J, Klotz U, et al: Pharmacokinetics and pharmacodynamics of propofol in a new solvent. Anesth Analg 1997;85:1399-1403.
10. Schnider TW, Minto CF, Gambus PL, Andresen C, Goodale DB, Shafer SL, et al: The influence of method of administration and covariates on the pharmacokinetics of propofol in adult volunteers. Anesthesiology 1998;88:1170-1182.
11. Knibbe CAJ, Voortman HJ, Aarts LPHJ, Kuks PFM, Lange R, Langemeijer HJM, et al: Pharmacokinetics, induction of anaesthesia and safety characteristics of propofol 6% SAZN vs propofol 1% SAZN and Diprivan-10 after bolus injection. Br J Clin Pharmacol 1999;47:653-660.
12. Knibbe CAJ, Aarts LPHJ, Kuks PFM, Voortman HJ, Lie-A-Huen L, Bras LJ, et al: Pharmacokinetics and pharmacodynamics of propofol 6% SAZN versus propofol 1% SAZN and Diprivan-10 for short-term sedation following coronary artery bypass surgery. Eur J Clin Pharmacol 2000;56:89-95.
13. Kay NH, Sear JW, Uppington J, Cockshott ID, Douglas EJ: Disposition of propofol in patients undergoing surgery: a comparison in men and women. Br J Anaesth 1986;58:1075-1079.
14. Cockshott ID, Briggs LP, Douglas EJ, White M: Pharmacokinetics of propofol in female patients: studies using single bolus injections. Br J Anaesth 1987;59:1103-1110.
15. Kirkpatrick T, Cockshott ID, Douglas EJ, Nimmo WS: Pharmacokinetics of propofol (Diprivan) in elderly patients. Br J Anaesth 1988;60:146-150.
16. Wessen A, Persson PM, Nilsson A, Hartvig P: Concentration-effect relationships of propofol after total intravenous anesthesia. Anesth Analg 1993;77:1000-1007.
17. Schüttler J, Stoeckel H, Schwilden H: Pharmacokinetics and pharmacodynamic modelling of propofol (Diprivan) in volunteers and surgical patients. Postgrad Med J 1985;61(Suppl. 3):53-54.